Kinnevik Investment

Babylon goes the SPAC route, Kinnevik to book SEK1.8bn in excess value

03/06/21 -"Following the holding company’s 31 May ad hoc announcement regarding a potential listing of Babylon Health, Kinnevik has just confirmed that the company will go public through a SPAC merger ..."

PDF page sample
Pages
59
Language
English
Published on
03/06/21
Download
You may also be interested by these reports :
01/07/26
Our EPS for 2027 is positively impacted by the announced acquisition of a 20% stake in FMC. Indeed, the additional interest costs related to the ...
01/07/26
Tessenderlo announced a $400m minority investment in US-listed FMC Corporation specializing in pesticides, a move that would potentially redefine the ...
29/06/26
Prosus delivered another high-quality set of results, beating consensus across all major operating metrics while further improving profitability and ...
29/06/26
We have significantly lowered our EPS estimates for Porsche SE, reflecting a weaker profitability outlook for both Volkswagen and Porsche AG, ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO